These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27167152)

  • 1. Respondent selection in a repeated survey on lifestyle within the randomized colorectal cancer screening programme.
    Jäntti M; Heinävaara S; Helander S; Sarkeala T; Malila N
    Eur J Cancer Prev; 2017 Jul; 26(4):309-313. PubMed ID: 27167152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of colorectal cancer screening on health status in a survey study.
    Jäntti M; Heinävaara S; Malila N; Sarkeala T
    Acta Oncol; 2018 Dec; 57(12):1605-1610. PubMed ID: 30198365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle in population-based colorectal cancer screening over 2-year follow-up.
    Helander S; Heinävaara S; Sarkeala T; Malila N
    Eur J Public Health; 2018 Apr; 28(2):333-338. PubMed ID: 29020299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of non-participation in a mass screening program for colorectal cancer in Finland.
    Artama M; Heinävaara S; Sarkeala T; Prättälä R; Pukkala E; Malila N
    Acta Oncol; 2016 Jul; 55(7):870-4. PubMed ID: 27152755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial.
    Berstad P; Løberg M; Larsen IK; Kalager M; Holme Ø; Botteri E; Bretthauer M; Hoff G
    Gut; 2015 Aug; 64(8):1268-76. PubMed ID: 25183203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a pre-screening survey on attendance in colorectal cancer screening: a double-randomized study in Finland.
    Helander S; Hakama M; Malila N
    J Med Screen; 2014 Jun; 21(2):82-8. PubMed ID: 24803481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle and occupational factors associated with participation in colorectal cancer screening among men and women in Australia.
    Carey RN; El-Zaemey S
    Prev Med; 2019 Sep; 126():105777. PubMed ID: 31319115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic features and patterns of non-participation in colorectal cancer screening in Finland.
    Jäntti M; Heinävaara S; Malila N; Sarkeala T
    Eur J Public Health; 2021 Oct; 31(4):890-894. PubMed ID: 34347069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
    Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing generalizability of the findings of sigmoidoscopy screening trials: the case of SCORE trial.
    Senore C; Bonelli L; Sciallero S; Casella C; Santarelli A; Armaroli P; Zanetti R; Segnan N
    J Natl Cancer Inst; 2015 Jan; 107(1):385. PubMed ID: 25492939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy.
    Brenner H; Chang-Claude J; Jansen L; Knebel P; Stock C; Hoffmeister M
    Gastroenterology; 2014 Mar; 146(3):709-17. PubMed ID: 24012982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
    Doria-Rose VP; Levin TR; Palitz A; Conell C; Weiss NS
    Gut; 2016 Feb; 65(2):271-7. PubMed ID: 25512639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spillover improved survival in non-invited patients of the colorectal cancer screening programme.
    Miettinen J; Malila N; Hakama M; Pitkäniemi J
    J Med Screen; 2018 Sep; 25(3):134-140. PubMed ID: 28782403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embedded survey study harms colorectal cancer screening attendance: Experiences from Finland 2010 to 2015.
    Helander S; Sarkeala T; Malila N
    J Med Screen; 2018 Mar; 25(1):51-54. PubMed ID: 28372514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey.
    Knudsen MD; Hoff G; Tidemann-Andersen I; Bodin GE; Øvervold S; Berstad P
    J Cancer Educ; 2021 Oct; 36(5):957-964. PubMed ID: 32112366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Colorectal Cancer Among Jordanians: a Case- Control Study.
    Khatatbeh MM; Jadallah KA; AL Bashtawy M; Hamaydeh SA; Gharaibeh MA; Kanaan NB; Alsmadi BM
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):577-581. PubMed ID: 29481028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.